Relapse risk prediction for children with henoch-schonlein purpura based on GA-SVM

被引:0
|
作者
Liu Y. [1 ]
Wang B. [2 ]
Li R. [1 ]
He S. [1 ]
Xi H. [1 ]
Luo Y. [1 ]
机构
[1] Key Laboratory of Cloud Computing and Intelligent Information Processing of Changzhou City, Jiangsu University of Technology, 1801 Zhongwu Road, Changzhou
[2] Department of Pediatrics, Changzhou No. 2 People's Hospital, 29 Xinglong Road, Changzhou
关键词
Genetic algorithm; Henoch-Schönlein purpura; Prediction of relapse risk; Support vector machine;
D O I
10.7546/ijba.2020.24.2.000608
中图分类号
学科分类号
摘要
The relapse risk prediction for children with Henoch-Schonlein purpura can help pediatricians make an accurate prognosis and offer personalized and appropriate follow-up nursing and relapse control to patients. In this study, we propose a Genetic algorithm-Support vector machine (GA-SVM) learning method combining the support vector machine with the genetic algorithm for parameter optimization to capture the nonlinear mapping from a panel of biomarkers to the relapse risk of HSP children. The GA-SVM prediction model is created by using the dataset of 40 samples in clinical treatment and observation of patients. The inputs of the model consist of 19 biomarkers including gender, age, immunoglobulin M, immunoglobulin G, immunoglobulin A, prothrombin time, etc. The outputs consist of 1 and-1, where 1 indicates high relapse risk and-1 indicates low relapse risk. For comparison, the GS-SVM prediction model based on parameter optimization of grid search is also created. The experimental results show that the GA-SVM prediction model has a high prediction accuracy of 90% and is strong in generalization ability. The GA-SVM model for predicting the relapse risk of HSP children is a promising decision support tool of clinical prognosis, which provides pediatricians with valuable assistance to offer rehabilitation treatment to patients. © 2020 by the authors.
引用
收藏
页码:117 / 130
页数:13
相关论文
共 50 条
  • [21] Henoch-Schonlein purpura
    Marinella, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (03): : 278 - 278
  • [22] Henoch-Schonlein purpura
    Tizard, E. J.
    Hamilton-Ayres, M. J. J.
    ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 2008, 93 (01): : 1 - 8
  • [23] Henoch-Schonlein Purpura
    Murlistyarini, S.
    Brahmanti, H.
    Widiatmoko, A.
    Rofiq, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 19 - 19
  • [24] HENOCH-SCHONLEIN PURPURA
    TAPSON, KMP
    AMERICAN FAMILY PHYSICIAN, 1993, 47 (03) : 633 - 638
  • [25] Henoch-Schonlein purpura
    Huppertz, H. -I.
    MONATSSCHRIFT KINDERHEILKUNDE, 2006, 154 (09) : 865 - 871
  • [26] Predictive Factors of Relapse in Adult With Henoch-Schonlein Purpura
    Byun, Ji-Won
    Song, Hee-Jin
    Kim, Lucia
    Shin, Jeong-Hyun
    Choi, Gwang-seong
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2012, 34 (02) : 139 - 144
  • [27] Henoch-Schonlein purpura
    Joseph, PR
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1998, 152 (07): : 715 - 715
  • [28] Henoch-Schonlein purpura
    Tizard, EJ
    ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (04) : 380 - 383
  • [29] HENOCH-SCHONLEIN PURPURA
    DUQUESNOY, B
    BAILLIERES CLINICAL RHEUMATOLOGY, 1991, 5 (02): : 253 - 261
  • [30] HENOCH-SCHONLEIN PURPURA
    HENG, MCY
    BRITISH JOURNAL OF DERMATOLOGY, 1985, 112 (02) : 235 - 240